Aristides Capital »

Heron Therapeutics shares owned by Aristides Capital

Quarter-by-quarter ownership of Heron Therapeutics (HRTX) shares owned by Aristides Capital from 13F filings

Historical chart of Aristides Capital investment in Heron Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Heron Therapeutics held by Aristides Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Heron Therapeutics by Aristides Capital

Quarter filed Position value Share count Share price at filing
2024-12-31 $81k 53k 1.53

More positions owned by Aristides Capital

Tesla Put Put Option
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Bitcoin Trust Etf Call Call Option
Ishares Bitcoin Trust Etf Put Put Option
Rigetti Computing Put Put Option
Ionq Put Put Option
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Ark Etf Tr Call Call Option
Quantum Computing Put Put Option
Alphabet Cap Stk Cl A (GOOGL)
Carvana Put Put Option
California Res Corp Com Stock (CRC)
Ituran Location And Control SHS (ITRN)
D-wave Quantum Put Put Option
Strategy Put Put Option

View all positions for Aristides Capital

Top funds holding Heron Therapeutics

Rubric Capital Management
Adage Capital Partners GP
BlackRock
Clearline Capital
Velan Capital Investment Management
Vanguard Group
Palisade Capital Management
Tejara Capital
Baker Bros. Advisors
State Street Corporation
Geode Capital Management
Tang Capital Management
JW Asset Management
D. E. Shaw & Co
UBS Group

View all funds holding Heron Therapeutics